Pharmaceuticals Removed from Chemicals of Concern List
Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed
July 2009 50-06-6 Phenobarbital pharm Dec_2011
July 2009 50-28-2 oestradiol pharm Dec_2011
July 2009 50-35-1 Thalidomide pharm Dec_2011
July 2009 50-36-2 Cocaine pharm Dec_2011
July 2009 50-41-9 Clomiphene citrate pharm Dec_2011
July 2009 50-53-3 chlorpromazine pharm Dec_2011
July 2009 50-55-5 Reserpine pharm Dec_2011
July 2009 50-76-0 Actinomycin D pharm Dec_2011
July 2009 50-78-2 Aspirin pharm Dec_2011
July 2009 51-21-8 Fluorouracil pharm Dec_2011
July 2009 51-52-5 Propylthiouracil pharm Dec_2011
July 2009 51-64-9 dextroamphetamine pharm Dec_2011
July 2009 51-75-2 Nitrogen mustard (Mechlorethamine) pharm Dec_2011
July 2009 51-98-9 Norethisterone acetate (Norethindrone acetate) pharm Dec_2011
July 2009 52-01-7 Spironolactone pharm Dec_2011
July 2009 52-24-4 Tris(1-aziridinyl)phosphine sulfide (Thiotepa) pharm Dec_2011
July 2009 52-28-8 Codeine phosphate pharm Dec_2011
July 2009 52-67-5 Penicillamine pharm Dec_2011
July 2009 52-86-8 Haloperidol pharm Dec_2011
July 2009 53-16-7 oestron pharm Dec_2011
July 2009 54-62-6 Aminopterin pharm Dec_2011
July 2009 54-91-1 Pipobroman pharm Dec_2011
July 2009 55-86-7 Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) pharm Dec_2011
July 2009 55-98-1 1,4-Butanediol dimethanesulfonate (Busulfan) pharm Dec_2011
July 2009 56-04-2 Methylthiouracil pharm Dec_2011
July 2009 56-53-1 diethylstilbestrol pharm Dec_2011
July 2009 56-75-7 Chloramphenicol pharm Dec_2011
July 2009 57-33-0 Pentobarbital sodium pharm Dec_2011
July 2009 57-53-4 Meprobamate pharm Dec_2011
July 2009 57-57-8 beta-Propiolactone pharm Dec_2011
July 2009 57-63-6 17-ethynylestradiol pharm Dec_2011
July 2009 57-83-0 Progesterone pharm Dec_2011
July 2009 58-18-4 Methyltestosterone pharm Dec_2011
July 2009 58-20-8 Testosterone cypionate pharm Dec_2011
July 2009 58-22-0 Testosterone and its esters pharm Dec_2011
July 2009 58-25-3 Chlordiazepoxide pharm Dec_2011
July 2009 59-05-2 Methotrexate pharm Dec_2011
July 2009 59-66-5 Acetazolamide pharm Dec_2011
July 2009 59-92-7 Levodopa pharm Dec_2011
July 2009 59-96-1 Phenoxybenzamine pharm Dec_2011
July 2009 60-54-8 Tetracycline (internal use) pharm Dec_2011
July 2009 60-56-0 Methimazole pharm Dec_2011 Pharmaceuticals Removed from Chemicals of Concern List
Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed
July 2009 61-57-4 Niridazole pharm Dec_2011
July 2009 62-44-2 Phenacetin pharm Dec_2011
July 2009 64-73-3 Demeclocycline hydrochloride (internal use) pharm Dec_2011
July 2009 64-75-5 Tetracycline hydrochloride (internal use) pharm Dec_2011
July 2009 64-86-8 Colchicine pharm Dec_2011
July 2009 66-75-1 Uracil mustard pharm Dec_2011
July 2009 66-76-2 Dicumarol pharm Dec_2011
July 2009 67-20-9 Nitrofurantoin pharm Dec_2011
July 2009 67-45-8 Furazolidone pharm Dec_2011
July 2009 68-22-4 Norethisterone (Norethindrone) pharm Dec_2011
July 2009 68-23-5 Norethynodrel pharm Dec_2011
July 2009 68-90-6 benziodarone pharm Dec_2011
July 2009 72-33-3 mestranol pharm Dec_2011
July 2009 76-43-7 Fluoxymesterone pharm Dec_2011
July 2009 84-17-3 Dienestrol pharm Dec_2011
July 2009 99-66-1 Valproate (Valproic acid) pharm Dec_2011
July 2009 126-85-2 Nitrogen mustard N-oxide pharm Dec_2011
July 2009 127-07-1 Hydroxyurea pharm Dec_2011
July 2009 127-48-0 Trimethadione pharm Dec_2011
July 2009 141-90-2 Thiouracil pharm Dec_2011
July 2009 143-67-9 Vinblastine sulfate pharm Dec_2011
July 2009 143-81-7 Butabarbital sodium pharm Dec_2011
July 2009 147-94-4 Cytarabine pharm Dec_2011
July 2009 148-82-3 Melphalan pharm Dec_2011
July 2009 151-67-7 Halothane pharm Dec_2011
July 2009 154-42-7 Thioguanine pharm Dec_2011
July 2009 154-93-8 Bischloroethyl nitrosourea (BCNU) (Carmustine) pharm Dec_2011
July 2009 298-46-4 Carbamazepine pharm Dec_2011
July 2009 300-62-9 amphetamine pharm Dec_2011
July 2009 302-70-5 Nitrogen mustard N-oxide hydrochloride pharm Dec_2011
July 2009 302-79-4 All-trans retinoic acid pharm Dec_2011
July 2009 305-03-3 Chlorambucil pharm Dec_2011
July 2009 309-43-3 Secobarbital sodium pharm Dec_2011
July 2009 315-37-7 Testosterone enanthate pharm Dec_2011
July 2009 320-67-2 Azacitidine pharm Dec_2011
July 2009 364-98-7 Diazoxide pharm Dec_2011
July 2009 366-70-1 Procarbazine hydrochloride pharm Dec_2011
July 2009 379-79-3 Ergotamine tartrate pharm Dec_2011
July 2009 389-08-2 Nalidixic acid pharm Dec_2011
July 2009 434-07-1 Oxymetholone pharm Dec_2011
July 2009 435-97-2 Phenprocoumon pharm Dec_2011
July 2009 438-41-5 Chlordiazepoxide hydrochloride pharm Dec_2011 Pharmaceuticals Removed from Chemicals of Concern List
Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed
July 2009 439-14-5 Diazepam pharm Dec_2011
July 2009 446-86-6 Azathioprine pharm Dec_2011
July 2009 474-25-9 Chenodiol pharm Dec_2011
July 2009 484-20-8 5-Methoxypsoralen with ultraviolet A therapy pharm Dec_2011
July 2009 505-60-2 Mustard Gas pharm Dec_2011
July 2009 531-76-0 Merphalan pharm Dec_2011
July 2009 531-86-2 benzidine sulfate pharm Dec_2011
July 2009 536-33-4 Ethionamide pharm Dec_2011
July 2009 537-46-2 methamphetamine pharm Dec_2011
July 2009 564-25-0 Doxycycline (internal use) pharm Dec_2011
July 2009 590-96-5 Methylazoxymethanol pharm Dec_2011
July 2009 595-33-5 Megestrol acetate pharm Dec_2011
July 2009 604-75-1 Oxazepam pharm Dec_2011
July 2009 630-93-3 Diphenylhydantoin (Phenytoin), sodium salt pharm Dec_2011
July 2009 637-07-0 Clofibrate pharm Dec_2011
July 2009 645-05-6 Altretamine pharm Dec_2011
July 2009 665-66-7 Amantadine hydrochloride pharm Dec_2011
July 2009 671-16-9 Procarbazine pharm Dec_2011
July 2009 749-13-3 trifluperidol pharm Dec_2011
July 2009 797-63-7 Levonorgestrel implants pharm Dec_2011
July 2009 846-49-1 Lorazepam pharm Dec_2011
July 2009 846-50-4 Temazepam pharm Dec_2011
July 2009 919-16-4 Lithium citrate pharm Dec_2011
July 2009 1172-18-5 Flurazepam hydrochloride pharm Dec_2011 July 2009 1405-10-3 Neomycin sulfate (internal use) pharm Dec_2011
July 2009 1620-21-9 Chlorcyclizine hydrochloride pharm Dec_2011
July 2009 2062-78-4 pimozide pharm Dec_2011
July 2009 2068-78-2 Vincristine sulfate pharm Dec_2011
July 2009 3546-10-9 Phenesterin pharm Dec_2011
July 2009 3771-19-5 Nafenopin pharm Dec_2011
July 2009 3963-95-9 Methacycline hydrochloride pharm Dec_2011
July 2009 4291-63-8 Cladribine pharm Dec_2011
July 2009 4342-03-4 Dacarbazine pharm Dec_2011
July 2009 4394-00-7 niflumic acid pharm Dec_2011
July 2009 4759-48-2 Isotretinoin pharm Dec_2011
July 2009 5104-49-4 Flurbiprofen pharm Dec_2011
July 2009 5534-09-8 Beclomethasone dipropionate pharm Dec_2011
July 2009 6055-19-2 Cyclophosphamide (hydrated) pharm Dec_2011
July 2009 6112-76-1 Mercaptopurine pharm Dec_2011
July 2009 6190-39-2 Dihydroergotamine mesylate pharm Dec_2011
July 2009 6533-00-2 Norgestrel pharm Dec_2011
July 2009 7632-10-2 methamphetamine pharm Dec_2011 Pharmaceuticals Removed from Chemicals of Concern List
Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed
July 2009 9002-68-0 Menotropins pharm Dec_2011
July 2009 10043-66-0 Iodine-131 pharm Dec_2011
July 2009 10418-03-8 Stanozolol pharm Dec_2011
July 2009 10540-29-1 Tamoxifen and its salts pharm Dec_2011
July 2009 13292-46-1 Rifampin pharm Dec_2011
July 2009 13311-84-7 Flutamide pharm Dec_2011
July 2009 13614-98-7 Minocycline hydrochloride (internal use) pharm Dec_2011
July 2009 13647-35-3 Trilostane pharm Dec_2011
July 2009 14028-44-5 Amoxapine pharm Dec_2011
July 2009 15475-56-6 Methotrexate sodium pharm Dec_2011
July 2009 15663-27-1 Cisplatin pharm Dec_2011
July 2009 17086-28-1 Doxycycline monohydrate (internal use) pharm Dec_2011
July 2009 17230-88-5 Danazol pharm Dec_2011
July 2009 18378-89-7 Plicamycin pharm Dec_2011
July 2009 21739-91-3 Cytembena pharm Dec_2011
July 2009 21829-25-4 Nifedipine pharm Dec_2011
July 2009 22494-42-4 Diflunisal pharm Dec_2011
July 2009 23092-17-3 Halazepam pharm Dec_2011
July 2009 23214-92-8 Adriamycin pharm Dec_2011
July 2009 23593-75-1 clotrimazole pharm Dec_2011
July 2009 24390-14-5 Doxycycline hyclate (internal use) pharm Dec_2011
July 2009 25122-46-7 Clobetasol propionate pharm Dec_2011
July 2009 25316-40-9 Doxorubicin hydrochloride (Adriamycin) pharm Dec_2011
July 2009 25812-30-0 Gemfibrozil pharm Dec_2011
July 2009 29122-68-7 Atenolol pharm Dec_2011
July 2009 29767-20-2 Teniposide pharm Dec_2011
July 2009 31431-39-7 Mebendazole pharm Dec_2011
July 2009 33069-62-4 Paclitaxel pharm Dec_2011
July 2009 33286-22-5 Diltiazem hydrochloride pharm Dec_2011
July 2009 33419-42-0 Etoposide pharm Dec_2011
July 2009 34031-32-8 Auranofin pharm Dec_2011
July 2009 36735-22-5 Quazepam pharm Dec_2011
July 2009 36791-04-5 Ribavirin pharm Dec_2011
July 2009 38194-50-2 Sulindac pharm Dec_2011
July 2009 38260-01-4 Trientine hydrochloride pharm Dec_2011
July 2009 39831-55-5 Amikacin sulfate pharm Dec_2011
July 2009 41340-25-4 Etodolac pharm Dec_2011
July 2009 41575-94-4 Carboplatin pharm Dec_2011
July 2009 49842-07-1 Tobramycin sulfate pharm Dec_2011
July 2009 52468-60-7 sibelium pharm Dec_2011
July 2009 53910-25-1 Pentostatin pharm Dec_2011
July 2009 54350-48-0 Etretinate pharm Dec_2011 Pharmaceuticals Removed from Chemicals of Concern List
Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed
July 2009 54749-90-5 Chlorozotocin pharm Dec_2011
July 2009 54965-24-1 Tamoxifen citrate pharm Dec_2011
July 2009 56391-57-2 Netilmicin sulfate pharm Dec_2011
July 2009 57109-90-7 Clorazepate dipotassium pharm Dec_2011
July 2009 57852-57-0 Idarubicin hydrochloride pharm Dec_2011
July 2009 59122-46-2 Misoprostol pharm Dec_2011
July 2009 59467-96-8 Midazolam hydrochloride pharm Dec_2011
July 2009 59865-13-3 Cyclosporin A pharm Dec_2011
July 2009 65807-02-5 Goserelin acetate pharm Dec_2011
July 2009 66085-59-4 Nimodipine pharm Dec_2011
July 2009 66852-54-8 Halobetasol propionate pharm Dec_2011
July 2009 68844-77-9 astemizole pharm Dec_2011
July 2009 70476-82-3 Mitoxantrone hydrochloride pharm Dec_2011
July 2009 74381-53-6 Leuprolide acetate pharm Dec_2011
July 2009 75330-75-5 Lovastatin pharm Dec_2011
July 2009 79217-60-0 Cyclosporine pharm Dec_2011
July 2009 80474-14-2 Fluticasone propionate pharm Dec_2011
July 2009 81103-11-9 Clarithromycin pharm Dec_2011
July 2009 81131-70-6 Pravastatin sodium pharm Dec_2011
July 2009 82410-32-0 Ganciclovir pharm Dec_2011
July 2009 82952-64-5 Trimetrexate glucuronate pharm Dec_2011
July 2009 97048-13-0 Urofollitropin pharm Dec_2011
July 2009 107910-75-8 Ganciclovir sodium pharm Dec_2011
July 2009 111406-87-2 Zileuton pharm Dec_2011
July 2009 113852-37-2 Cidofovir pharm Dec_2011
July 2009 N/A Aminoglycosides pharm Dec_2011
July 2009 N/A Analgesic mixtures containing phenacetin pharm Dec_2011
July 2009 N/A Angiotensin converting enzyme (ACE) inhibitors pharm Dec_2011
July 2009 N/A Barbiturates pharm Dec_2011
July 2009 N/A Benzodiazepines pharm Dec_2011
July 2009 N/A Conjugated estrogens pharm Dec_2011
July 2009 N/A Estrogens, nonsteroidal pharm Dec_2011
July 2009 N/A Estrogens, steroidal pharm Dec_2011
July 2009 N/A Anabolic steroids pharm Dec_2011
July 2009 N/A Estrogen therapy, postmenopausal pharm Dec_2011
July 2009 N/A Estrogen-progestogen menopausal therapy (combined) pharm Dec_2011
July 2009 N/A Estrogen-progestogen oral contraceptives (combined) pharm Dec_2011
July 2009 N/A MOPP and other combined chemotherapy including alkylating agents pharm Dec_2011
July 2009 N/A Oral contraceptives, combined pharm Dec_2011
July 2009 N/A Oral contraceptives, combined estrogen-progestogen pharm Dec_2011
July 2009 N/A Oral contraceptives, sequential pharm Dec_2011